Here’s what to expect from the current minimally-invasive glaucoma surgery options.
Optimize therapy and extension strategies to help patients tolerate those never-ending injections.
Review of Ophthalmology Online eNewsletter
IN THIS ISSUE:
- Retinal Leakage Index Dynamics on Ultra-Widefield FA in Eyes Treated with Intravitreal Aflibercept for PDR: RECOVERY Study
- Private Equity in U.S. Ophthalmology & Optometry: Acquisitions from 2012 to 2019
- Efficacy of a T&E Regimen with Ranibizumab in nAMD
- Comparing Two Techniques for Graft Implantation in DMEK